Pine Labs Limited has announced scheduled one-on-one meetings with investors to be held in Hong Kong on March 23-24, 2026. The company filed this intimation with stock exchanges on March 17, 2026, under Regulation 30 compliance requirements.

Meeting Details

The investor meetings are structured as follows:

Regulatory Compliance

Pine Labs has specifically notified that the company will not be disclosing any Unpublished Price Sensitive Information (UPSI) during the upcoming analyst and investor meetings. This declaration ensures compliance with regulatory requirements governing investor interactions and information disclosure norms.

The company secretary and compliance officer Neerav Mehta (Membership Number: A20949) signed the regulatory filing on March 17, 2026. The intimation was simultaneously submitted to both BSE Limited and National Stock Exchange of India Limited.

Information Accessibility

Pine Labs has confirmed that details regarding these investor meetings will be made available on the company's official website under the investor relations section at pinelabs.com/investor-relations. This ensures transparency and provides stakeholders with easy access to meeting-related information.

The scheduled meetings represent Pine Labs' ongoing engagement with the investment community through direct investor interactions in the Hong Kong market.

Pine Labs has received a substantial acquisition disclosure from SBI Mutual Fund after the fund house crossed the 5% shareholding threshold through a market purchase transaction completed on February 23, 2026.

Acquisition Details

SBI Mutual Fund, operating under its various schemes, acquired 2,40,000 shares of Pine Labs on February 23, 2026. This acquisition represents 0.0209% of the company's total share capital and pushed the fund's total shareholding above the 5% threshold that triggers mandatory disclosure requirements under SEBI regulations.

Regulatory Compliance

The acquisition triggered reporting requirements under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. SBI Funds Management Limited, through its Chief Compliance Officer & Company Secretary, formally notified Pine Labs of the substantial acquisition on February 24, 2026.

The disclosure was also submitted to both major stock exchanges where Pine Labs shares are listed:

• National Stock Exchange of India Limited
• BSE Limited

Company Share Capital Structure

Pine Labs' equity share capital remained unchanged following the transaction:

Fund House Position

SBI Mutual Fund's final holding position as of the close of business hours on February 23, 2026, stands at 5,75,82,504 shares. The fund house confirmed that it does not belong to the promoter or promoter group of Pine Labs and holds no encumbrances, voting rights other than equity shares, or convertible securities in the company.

The acquisition represents a strategic investment by one of India's leading mutual fund houses in the fintech company, reflecting institutional confidence in Pine Labs' business prospects.